Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8780523rdf:typepubmed:Citationlld:pubmed
pubmed-article:8780523lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8780523lifeskim:mentionsumls-concept:C0284162lld:lifeskim
pubmed-article:8780523lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:8780523lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:8780523pubmed:issue34lld:pubmed
pubmed-article:8780523pubmed:dateCreated1996-10-16lld:pubmed
pubmed-article:8780523pubmed:abstractTextHuman alpha-1,3-fucosyltransferase catalyzes the transfer of the L-fucose moiety from guanosine diphosphate-beta-L-fucose (GDP-Fuc) to acceptor sugars to form biologically important fucoglycoconjugates, including sialyl Lewis x (SLex). Evidence for a general base mechanism is supported by a pH-rate profile that revealed a catalytic residue with a pKa of 4.1. The characterized solvent kinetic isotope effect (Dv = 2.9, Dv/k = 2.1) in a proton inventory study indicates that only one-proton transfer is involved in the catalytic step leading to the formation of the transition state. Evidence for Mn2+ as an electrophilic catalyst was supported by the observation that the nonenzymatic transfer of L-fucose from GDP-Fuc to the hydroxyl group of water in the presence of 10 mM MnCl2 at 20 degrees C was accelerated from K(obs)= 3.5 x 10(-6) to 3.8 x 10(-5) min-1. Using the GDP-Fuc hydrolysis as the nonenzymatic rate, the enzymatic proficiency of FucT V, (Kcat/Ki,GDP-fuc. K(m),1.acNAc)/K(non), was estimated to be 1.2 x 10(10) M-1 with a transition-state affinity of 8.6 x 10(-11) M. The Km for Mn2+ was determined to be 6.1 mM, and alternative divalent metal cofactors were identified as Ca2+, Co2+, and Mg2+. Detailed kinetic characterization of the acceptor sugar specificity indicated that incorporation of hydrophobic functionality [e.g. -O-(CH2)5CO2CH3] to the reducing end of the acceptor sugar substantially decreased the K(m),acceptor by over 100-fold. The role of the nucleotide was investigated by studying the inhibition of nucleotides, including the guanosine series. The inhibitory potency trend (GTP approximately GDP > GMP > > guanosine) is consistent with bidentate chelation of Mn2+ by GDP-Fuc. The role of charge and distance in the synergistic inhibitory effect by the combination of GDP, an aza sugar, and the acceptor sugar was probed. A mechanism for fucosyl transfer incorporating these findings is proposed and discussed.lld:pubmed
pubmed-article:8780523pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:languageenglld:pubmed
pubmed-article:8780523pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:citationSubsetIMlld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8780523pubmed:statusMEDLINElld:pubmed
pubmed-article:8780523pubmed:monthAuglld:pubmed
pubmed-article:8780523pubmed:issn0006-2960lld:pubmed
pubmed-article:8780523pubmed:authorpubmed-author:SchultzJJlld:pubmed
pubmed-article:8780523pubmed:authorpubmed-author:TakayamaSSlld:pubmed
pubmed-article:8780523pubmed:authorpubmed-author:WongC HCHlld:pubmed
pubmed-article:8780523pubmed:authorpubmed-author:MurrayB WBWlld:pubmed
pubmed-article:8780523pubmed:issnTypePrintlld:pubmed
pubmed-article:8780523pubmed:day27lld:pubmed
pubmed-article:8780523pubmed:volume35lld:pubmed
pubmed-article:8780523pubmed:ownerNLMlld:pubmed
pubmed-article:8780523pubmed:authorsCompleteYlld:pubmed
pubmed-article:8780523pubmed:pagination11183-95lld:pubmed
pubmed-article:8780523pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:meshHeadingpubmed-meshheading:8780523-...lld:pubmed
pubmed-article:8780523pubmed:year1996lld:pubmed
pubmed-article:8780523pubmed:articleTitleMechanism and specificity of human alpha-1,3-fucosyltransferase V.lld:pubmed
pubmed-article:8780523pubmed:affiliationDepartment of Chemistry, Scripps Research Institute, La Jolla, California 92037, USA.lld:pubmed
pubmed-article:8780523pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8780523pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8780523pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8780523lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8780523lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8780523lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8780523lld:pubmed